SCHEDULE 4
Part IIControlled Drugs excepted from the Prohibition on possession when in the form a Medicinal product;excluded from application of offences arising from the probition on importation and exportation when imported or exported in the form of a medicinal product by any person for administration to himself; and subject to the requirements of regulations 22, 23, 26 and 27
1.
The following substances, namely—
Atamestane
Bolandiol
Bolasterone
Bolazine
Boldenone
Bolenol
Bolmantalate
Calusterone
4-Chloromethandienone
Clostebol
Drostanolone
Enestobol
Epitiostanol
Ethyloestrenol
Fluoxymesterone
Formebolone
Furazabol
Mebolazine
Mepitiostane
Mesabolone
Mestanolone
Mesterolone
Methandienone
Methandriol
Methenolone
Methyltestosterone
Metribolone
Mibolerone
Nandrolone
Norboletone
Norclostebol
Norethandrolone
Ovandrotone
Oxabolone
Oxandrolone
Oxymesterone
Oxymetholone
Prasterone
Propetandrol
Quinbolone
Roxibolone
Silandrone
Stanolone
Stanozolol
Stenbolone
Testosterone
Thiomesterone
Trenbolone
2.
Any compound (not being Trilostane or a compound for the time being specified in paragraph 1 of this Part of this Schedule) structurally derived from 17-hydroxyandrostan-3-one or from 17-hydroxyestran-3-one by modification in any of the following ways, that is to say—
(a)
by further substitution at position 17 by a methyl or ethyl group;
(b)
by substitution to any extent at one or more of positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position;
(c)
by unsaturation in the carbocyclic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring;
(d)
by fusion of ring A with a heterocyclic system.
3.
Any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in paragraph 1 or described in paragraph 2 of this Part of this Schedule.
4.
The following substances, namely—
Chorionic Gonadotrophin (HCG)
Clenbuterol
Non-human chorionic gonadotrophin
Somatotropin
Somatrem
Somatropin
5.
Any stereoisomeric form of a substance specified or described in any of paragraphs 1 to 4 of this Part of this Schedule.
6.
Any salt of a substance specified or described in any of paragraphs 1 to 5 of this Part of this Schedule.
7.
Any preparation or other product containing a substance or product specified or described in any of paragraphs 1 to 6 of this Part of this Schedule, not being a preparation specified in Schedule 5.